Uppsala, Sweden

Helge Rask-Andersen

USPTO Granted Patents = 1 



Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Helge Rask-Andersen: Innovator in Hearing Health**

Introduction

Helge Rask-Andersen is a prominent inventor based in Uppsala, Sweden, recognized for his innovative contributions to the field of ear health. His focus on developing new methods for treating inner ear conditions has made a significant impact on the medical community.

Latest Patents

Rask-Andersen holds a patent titled "Method and compositions for local treatment of Meniere's disease, tinnitus and/or hearing loss." This patent describes a novel approach utilizing a therapeutically effective amount of a prostaglandin of the F-type administered to the inner ear. The method can be applied through continuous or intermittent treatment using various means such as pumps, gels, or slow-release drug delivery systems. This innovative solution aims to alleviate the symptoms associated with Meniere's disease, tinnitus, and hearing loss.

Career Highlights

Rask-Andersen is associated with Synphora AB, a company that emphasizes groundbreaking research and development in the realm of health technologies. His work, particularly in the local treatment of auditory disorders, showcases his commitment to improving patient outcomes and advancing medical science.

Collaborations

Rask-Andersen collaborates closely with his coworker, Johan W Stjernschantz. Together, they contribute to the development of new therapeutic approaches, further enhancing the capabilities and research at Synphora AB.

Conclusion

Helge Rask-Andersen stands out as an influential figure in the innovation landscape of hearing health. With his patented methods, he exemplifies the role of inventors in transforming healthcare through novel approaches. His contributions not only reflect his expertise but also pave the way for future advancements in treating auditory conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…